Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anglaret

Showing results (161-170 of 267) with videos related to

Pageof 27
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|April 21, 2010
Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: clinical benefits and cost-effectivenessApril D Kimmel, Milton C Weinstein, Xavier Anglaret, et al.
Sante (Montrouge, France)|March 1, 1997
[Primary chemoprevention of tuberculosis in HIV-infected patients in non-industrialized countries]X Anglaret, F Dabis, J Batungwanayo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 31, 2010
Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Côte d'IvoireEugène Messou, Marie-Laure Chaix, Delphine Gabillard, et al.
Bulletin of the World Health Organization|July 10, 2010
Scaling up antiretroviral therapy for HIV-infected children in Côte d'Ivoire: determinants of survival and loss to programmeM-F Anaky, J Duvignac, L Wemin, et al.
AIDS (London, England)|March 9, 2012
Projecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing ageEric N Ouattara, Xavier Anglaret, Angela Y Wong, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 23, 2011
Medication possession ratio: predicting and decreasing loss to follow-up in antiretroviral treatment programs in Côte d'IvoireEugène Messou, Martial Kouakou, Delphine Gabillard, et al.
BMC Infectious Diseases|January 30, 2022
Association of cellular HIV-1 DNA and virological success of antiretroviral treatment in HIV-infected sub-Saharan African adultsDesmorys Raoul Moh, Jean-Baptiste Ntakpé, Delphine Gabillard, et al.
Antiviral Therapy|April 9, 2015
Low risk of lamivudine-resistant HBV and hepatic flares in treated HIV-HBV-coinfected patients from Côte d'IvoireAnders Boyd, Raoul Moh, Delphine Gabillard, et al.
BMJ Open|January 12, 2024
Virological, serological and clinical outcomes in chronic hepatitis B virus infection: development and validation of the HEPA-B simulation modelAmir M Mohareb, Arthur Y Kim, Anders Boyd, et al.
Journal of Clinical Microbiology|June 16, 2005
Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited settingFrancois Rouet, Didier K Ekouevi, Marie-Laure Chaix, et al.
Pageof 27

Showing results (161-170 of 267) with videos related to

Sort By:
Pageof 27
Journal of Acquired Immune Deficiency Syndromes (1999)|April 21, 2010
Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: clinical benefits and cost-effectivenessApril D Kimmel, Milton C Weinstein, Xavier Anglaret, et al.
Sante (Montrouge, France)|March 1, 1997
[Primary chemoprevention of tuberculosis in HIV-infected patients in non-industrialized countries]X Anglaret, F Dabis, J Batungwanayo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 31, 2010
Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Côte d'IvoireEugène Messou, Marie-Laure Chaix, Delphine Gabillard, et al.
Bulletin of the World Health Organization|July 10, 2010
Scaling up antiretroviral therapy for HIV-infected children in Côte d'Ivoire: determinants of survival and loss to programmeM-F Anaky, J Duvignac, L Wemin, et al.
AIDS (London, England)|March 9, 2012
Projecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing ageEric N Ouattara, Xavier Anglaret, Angela Y Wong, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 23, 2011
Medication possession ratio: predicting and decreasing loss to follow-up in antiretroviral treatment programs in Côte d'IvoireEugène Messou, Martial Kouakou, Delphine Gabillard, et al.
BMC Infectious Diseases|January 30, 2022
Association of cellular HIV-1 DNA and virological success of antiretroviral treatment in HIV-infected sub-Saharan African adultsDesmorys Raoul Moh, Jean-Baptiste Ntakpé, Delphine Gabillard, et al.
Antiviral Therapy|April 9, 2015
Low risk of lamivudine-resistant HBV and hepatic flares in treated HIV-HBV-coinfected patients from Côte d'IvoireAnders Boyd, Raoul Moh, Delphine Gabillard, et al.
BMJ Open|January 12, 2024
Virological, serological and clinical outcomes in chronic hepatitis B virus infection: development and validation of the HEPA-B simulation modelAmir M Mohareb, Arthur Y Kim, Anders Boyd, et al.
Journal of Clinical Microbiology|June 16, 2005
Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited settingFrancois Rouet, Didier K Ekouevi, Marie-Laure Chaix, et al.
Pageof 27